Frailty and checkpoint inhibitor toxicity in older patients with melanoma.
Journal Information
Full Title: Cancer
Abbreviation: Cancer
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
2/6
33.3% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Conflict of Interest Disclosures José J. Koldenhof, reports institutional grants and consulting fees from Novartis outside the submitted work. Karijn P. M. Suijkerbuijk reports grants from AbbVie and Novartis; personal fees from Bristol Myers Squibb, Merck Sharpe & Dohme, Novartis, and Pierre‐Fabre; and honoraria from Merck Sharpe & Dohme and Roche outside the submitted work. The remaining authors made no disclosures."
Funding Disclosure
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025